The most luxurious organic mattress I've ever slept on is 27% off ahead of Memorial Day
A trend I never tire of seeing in the sleep industry is a move towards sustainability, ethics and quality products that last. This shift in priorities has seen a rise in natural mattresses, and I'm lucky enough to be sleeping on one at the moment. The Birch Natural Luxe is a hybrid latex bed that I've fallen in love with. And with our code TOMS27 you can get 27% off this Birch mattress ahead of Memorial Day.
We've tried and tested all the best organic mattresses of the year, each offering a different sleeping experience and addressing different needs. However, what they all have in common is a focus on using natural, organic and sustainable materials, like wool, cotton and latex, as opposed to man-made mattress materials that are chemical based, like memory foam.
The Birch Natural Luxe combines all three quality materials and it's the most luxurious mattress I've slept on. As an official convert to clean, non-toxic sleep, here's why I think this organic mattress is well worth investing in the Memorial Day mattress sales.
The Birch Natural Luxe mattress: twin was $1,624 now $1,185.52 with code TOMS27 at BirchThe Birch Natural Luxe is a medium-firm mattress made up of individually wrapped coils and layers of GOLS-certified natural latex, layers of Birch wool and an organic cotton cover. The mattress is Greenguard Gold certified as well, this mattress certification means it has ultra low VOC emissions. These VOCs are responsible for the strong chemical off-gassing that can occur with cheaper memory foam mattresses. The organic cotton euro pillow top is designed to offer pressure relief, while the latex and coils support your body and keep your spine aligned. As an organic, natural mattress, it sits at a premium price point with the MSRP of a queen being $2,624. However, using the TOMS27 code at checkout unlocks 27% off for Memorial Day, bringing the price down to $1,915.52, plus a free Eco-Rest Pillow Set. You'll also get industry-leading perks like a limited lifetime warranty, free shipping and a 100-night trialUser score: ★★★★ (670+ reviews)
I've only been sleeping on the Birch Natural Luxe for a week, so I'll write my full review after a month to see if it's worthy of a spot in our guide to the best mattresses of the year. However, my first impressions are fantastic. The combination of the cotton and wool gives the euro pillow top just enough 'give' to relieve the pressure at my hips, shoulders and knees. This is important, considering I'm primarily a side sleeper. It does have quite a firm feel, but I love the buoyancy of this. I'm not sinking into the bed, instead, I'm sleeping comfortably on top of it.
Sleeping on the Birch Natural Luxe genuinely feels 'clean'. The combination of the breathable and moisture-wicking materials means my partner and I don't wake up sweating, and despite sleeping on it with the summer temperatures rising, we haven't overheated once.
After sleeping on one of the best memory foam mattresses of the year, it feels really nice to sleep on an organic bed. There has been absolutely no off-gassing and swapping a synthetic, chemical material for an ethical, sustainable and natural alternative feels like the right decision for me.
Naturepedic Pillow Top Concerto mattress: twin was $1,699 now $1,359.20 with code MEMORIAL20 at NaturepedicA more plush alternative for those who enjoy a softer mattress, the Naturepedic Concerto is up there with the best luxury mattresses. Like the Birch, it combines natural latex, wool and cotton with coils to create a soft mattress that's perfect for side sleepers. In fact, our lead tester for the Naturepedic Pillow Top Concerto mattress review was surprised at how soft it felt. Like the best pillow top mattresses, the layer stitched on top contours to your body, relieving key areas where pressure points build up. A queen has an MSRP of $2,799, but the current 20% off Memorial Day deal means this price drops to $2,239.20 when you add the code MEMORIAL20. You'll also get a 100-night trial, free shipping and returns and a limited 25-year warranty.User score: ★★★★½ (10+ reviews)
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Upturn
3 hours ago
- Business Upturn
BrainDefender Research Announces Launch of New Cognitive Support Formula for Adults
Denver, June 06, 2025 (GLOBE NEWSWIRE) — BrainDefender Research today announced the launch of BrainDefender Memory Support Supplement , a new cognitive wellness formula developed to support focus, mental clarity, and memory in adults. Manufactured in a GMP-certified facility in the United States, the product is designed for individuals seeking to maintain healthy cognitive function through natural, plant-based supplementation. The new formula features a combination of Ginkgo Biloba, Bacopa Monnieri, Huperzine-A, Phosphatidylserine, and N-Acetyl-L-Carnitine—ingredients that have each been individually studied for their potential roles in brain function. BrainDefender Research emphasizes that the supplement is intended for use as part of a wellness routine to support cognitive performance and healthy aging. 'Consumer interest in natural brain support has grown significantly in recent years,' said a spokesperson for BrainDefender Research. 'We developed this product to offer adults a well-rounded option for supporting mental clarity, focus, and memory performance using recognizable, research-supported ingredients.' The company recommends consistent daily use over a 90-day period for best results and offers a 60-day refund policy for customer satisfaction. The product is available for purchase in 30-day, 90-day, and 180-day supply options to accommodate individual wellness goals. Availability BrainDefender Memory Support Supplement can be ordered directly through the company's official website and is also offered via the ClickBank platform. Domestic orders are typically delivered within 5–7 business days, while international shipping may take 10–12 business days. About BrainDefender Research BrainDefender Research is a U.S.-based wellness company focused on the development of cognitive support supplements using plant-based ingredients. All products are manufactured in GMP-certified facilities to ensure quality and safety in every batch. Disclaimer These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Individuals should consult a licensed healthcare provider before beginning any new supplement routine, especially if taking medications or managing a medical condition. Media Contact Email: [email protected] Phone: (855) 473-4405 Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same.
Yahoo
3 hours ago
- Yahoo
AMC Entertainment Draws Bigger Crowds as Investor Confidence Fades
AMC Entertainment (AMC) just posted its best Memorial Day weekend ever, setting new records for both ticket sales and concession revenue. But despite packed theaters and positive box office momentum, the stock has dropped more than 16% over the past week. The disconnect highlights a deeper issue: while strong movie turnout is encouraging, it's not enough to offset the company's underlying financial challenges. With lingering structural issues, ongoing meme-driven volatility, and more attractive opportunities elsewhere in the sector, I remain bearish on AMC for now. Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter There's no denying that AMC is enjoying some genuine momentum. The Memorial Day weekend was a clear highlight, as more than 7 million people went to an AMC to catch a movie (or two) over the holiday. This helped the company set new records for admissions, food and beverage sales, and overall revenue. Furthermore, the industry is experiencing upward trends. After a brutal start to 2025, the spring months brought a welcome turnaround. April's box office results were double what they were the previous year, suggesting that audiences are returning to theaters (finally). AMC is looking to ride the wave of returning moviegoers by doubling down on offering 'premium experiences', including upgraded seating, enhanced sound systems, and larger screens. These premium formats command higher ticket prices, which should help boost revenue per customer. Finally, the company has recently announced it is experimenting with new advertising strategies, potentially creating another revenue stream. Despite riding a rising tide and operational improvements, AMC's financial health remains problematic. The first quarter of 2025 was particularly challenging, with several key metrics heading in the wrong direction. Revenue dropped by 6.7% year-over-year, falling to $862.5 million. Furthermore, AMC reported a loss of $202.1 million for the quarter, compared to a loss of $163.5 million during the same period in 2024. The impact this has had on AMC's cash reserves is alarming. Cash levels have dropped dramatically from $632.3 million to just $378.7 million. This rapid cash burn is worrying. Ultimately, AMC's debt is a significant burden. The company carries a staggering $8.28 billion in total debt, with $43 million in debt payments due this year, $173 million next year, and a whopping $526 million in 2027. With less than $400 million in cash, its interest coverage ratio is now an anemic -0.18. AMC's leadership team remains bullish about the company's prospects. Management is projecting annual revenue growth of about 7% over the next three years. While this sounds encouraging, it's actually slightly below the average for the broader entertainment industry, suggesting AMC may continue to face headwinds even in a recovery scenario. Analysts following the company hold a mixed outlook for its prospects, rating it a Hold overall, with a 12-month price target of $2.92. Most recently, Texas Capital's Eric Wold rated AMC a Hold, with a price target of $3. Noting AMC's significant debt and upcoming maturities, he suggests cash flow challenges from rising interest expenses could impact the company's equity valuation. Meanwhile, B. Riley's Drew Crum has lowered the price target on AMC to $3, while maintaining a Neutral stance. He maintains a generally positive outlook for the industry, given a robust upcoming slate of Hollywood films that are expected to drive box office recovery. Citi analyst Jason Bazinet holds a more pessimistic view, recently reiterating a Sell rating. However, he slightly increased the price target to $2.60, citing changes in advertising forecasts amid reduced tariff concerns. Any discussion of AMC stock would be incomplete without addressing its 'meme stock' dynamics. Take May as an example—the share price nearly doubled within a matter of days, fueled by a wave of coordinated buying from retail investors on platforms like Reddit. These kinds of explosive moves have become a defining feature of AMC's trading behavior. But the rallies are usually fleeting. Once the hype dies down, the stock often gives back its gains as the company's underlying financial challenges come back into focus—something we've likely seen play out over the past week. While AMC's meme stock status can create bursts of excitement for short-term traders, it also brings extreme volatility. That volatility distorts traditional valuation metrics and skews technical indicators, such as moving averages, making it difficult to assess the stock through a conventional investment lens. The question for AMC ultimately revolves around whether resurgent demand and operational improvements can overcome its financial constraints. Until AMC can demonstrate consistent profitability and make meaningful progress in reducing its debt burden, positive box office trends will not be enough to sustain the stock (though ongoing meme-related volatility spikes are likely). I am inclined to avoid AMC until the company can demonstrate that it can turn its box office momentum into the kind of sustained financial performance that will help it climb out of its debt crater. Disclaimer & DisclosureReport an Issue Sign in to access your portfolio
Yahoo
8 hours ago
- Yahoo
The Nutriment Company expands again in Germany via M&A
The Nutriment Company has continued its acquisition spree with the takeover of German private-label pet-food business Graf Barf from CDS Hackner. The financial terms of the transaction were not disclosed. In a statement, Sweden-based The Nutriment Company said the acquisition is aimed at 'further strengthening its position as a leader in the natural, high-quality pet food segment'. The move comes two months after the Sweden-based group snapped up BAF Petfood from German peer Fressnapf. Graf Barf provides a range of raw pet food products, including complete meals, cube portions, and other formats. The German business also operates an 'IFS-certified, human-grade' production facility. The Nutriment Company said the deal would broaden its geographic reach in Germany, where it already markets brands such as Barfgold, DIBO, Nutriment and Aniforte. The transaction also 'lays the groundwork for a more accelerated expansion' into neighbouring markets, including Switzerland and Austria, it said. As part of the deal, The Nutriment Company has also teamed up with CDS Hackner to establish a frozen logistics hub to serve mainland Europe. CDS Hackner CEO and owner Michael Hackner said that the group will become The Nutriment Company's 'central logistics hub for Europe from our Crailsheim location and are ready to integrate Graf BARF into the TNC brand portfolio, passionately supporting the brand's continued growth." Headquartered in Stockholm and owned by Nordic PE firm Axcel, The Nutriment Company supplies 'natural premium' pet food. In April, The Nutriment Company executed its fifth acquisition of the year with the takeover of UK-based Bulmer Pet Foods. The pet-food supplier also entered Spain in February with the acquisition of Puromenu, a raw pet-food producer. "The Nutriment Company expands again in Germany via M&A" was originally created and published by Just Food, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
